The use of induced pluripotent stem cells to reveal pathogenic gene mutations and explore treatments for retinitis pigmentosa.
about
Induced Pluripotent Stem Cells and Outer Retinal DiseaseConcise Review: Patient-Specific Stem Cells to Interrogate Inherited Eye DiseaseAn Overview of Direct Somatic Reprogramming: The Ins and Outs of iPSCsTranslation of Human-Induced Pluripotent Stem Cells: From Clinical Trial in a Dish to Precision MedicineNeuroprotective effect of bilberry extract in a murine model of photo-stressed retinaInduced pluripotent stem cells: applications in regenerative medicine, disease modeling, and drug discovery.Personalized therapeutic strategies for patients with retinitis pigmentosa.Use of human pluripotent stem cells to study and treat retinopathiesiPS Cells for Modelling and Treatment of Retinal DiseasesUsing Stem Cells to Model Diseases of the Outer RetinaN- and O-glycan cell surface protein modifications associated with cellular senescence and human aging.Robust Differentiation of mRNA-Reprogrammed Human Induced Pluripotent Stem Cells Toward a Retinal LineageIn vitro transdifferentiation of human peripheral blood mononuclear cells to photoreceptor-like cells.Homology Requirements for Efficient, Footprintless Gene Editing at the CFTR Locus in Human iPSCs with Helper-dependent Adenoviral Vectors.Using induced pluripotent stem cells to understand retinal ciliopathy disease mechanisms and develop therapiesCurrent status of pluripotent stem cells: moving the first therapies to the clinic.Stepwise Differentiation of Retinal Ganglion Cells from Human Pluripotent Stem Cells Enables Analysis of Glaucomatous Neurodegeneration.Gene Editing with Helper-Dependent Adenovirus Can Efficiently Introduce Multiple Changes Simultaneously over a Large Genomic Region.Unraveling the mysteries of pre-mRNA splicing in the retina via stem cell technology.Neuroprotective role of retinal SIRT3 against acute photo-stress.Recent Advances in Retinal Stem Cell Therapy.Gene Correction Reverses Ciliopathy and Photoreceptor Loss in iPSC-Derived Retinal Organoids from Retinitis Pigmentosa Patients.Special Issue Introduction: Inherited Retinal Disease: Novel Candidate Genes, Genotype-Phenotype Correlations, and Inheritance Models.Dominant and recessive mutations in rhodopsin activate different cell death pathways.Quantitative analyses of factors related to anxiety and depression in patients with retinitis pigmentosa.Optogenetic Light Sensors in Human Retinal Organoids
P2860
Q26765906-F14816E8-6E8A-4C2F-90CE-04755164EC30Q26774786-73276713-0B8C-468A-BC86-CBBCA7EAD01CQ26775122-89C8A156-607B-47D5-9845-CE1D0A802DBBQ28076397-FB0A8C41-EFD3-4879-9E3E-E22D032147B4Q33751933-DEFACC62-08B0-4388-9D52-E93E30AA7973Q35037783-62707DF6-4C45-4980-9BB9-B225283A46DCQ35225949-07B0AE3A-7AC9-48DF-945A-D1304D6E0D7EQ35501343-76E29CA4-A17A-481E-9F2C-D85714C22316Q35750572-5DB6DF8D-D435-4529-946A-5E9C41D321DBQ35768469-9EDD636E-6FFC-434B-908C-BD72A43CC257Q36591856-744F3155-691E-469A-A33F-0DBFED9F79A1Q36702988-8E1445AA-BBC7-4B8C-ABF0-AF8521903FC8Q37036264-31BDE156-2879-4BB4-93C6-55B256DCAC15Q37393979-9B69B56D-E924-428D-B472-F62030679B70Q37588148-44F1579E-E863-4504-90D4-A4963E4FD52AQ38590664-CAE5A315-2947-41B4-8068-0A68A4E868F4Q38892613-C5780766-3296-4366-B488-0EEEC055E06CQ42149489-B727661B-4282-4878-8401-5447DDA12D0BQ42370397-9467AA14-222B-426C-B136-1FEA1839B958Q46246376-0DEF6D6D-7388-4C17-9BF3-6344DC2B2AD8Q49894761-5DD10F97-9E5F-4532-BC06-79A13A9ACF53Q51734789-78645100-B18C-475C-A761-9242736CF75DQ52586106-EDFC384E-DB9C-4604-89AC-C4D5A32EB134Q53611722-F1378D98-0BE7-4103-8CF2-F53875A65D7DQ55113998-C2277FB5-1B70-4954-9663-58BAD2CB2CE5Q59137485-CBCDF2B1-424D-4144-BF98-5BC3757D1078
P2860
The use of induced pluripotent stem cells to reveal pathogenic gene mutations and explore treatments for retinitis pigmentosa.
description
2014 nî lūn-bûn
@nan
2014 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
The use of induced pluripotent ...... ents for retinitis pigmentosa.
@ast
The use of induced pluripotent ...... ents for retinitis pigmentosa.
@en
type
label
The use of induced pluripotent ...... ents for retinitis pigmentosa.
@ast
The use of induced pluripotent ...... ents for retinitis pigmentosa.
@en
prefLabel
The use of induced pluripotent ...... ents for retinitis pigmentosa.
@ast
The use of induced pluripotent ...... ents for retinitis pigmentosa.
@en
P2093
P2860
P356
P1433
P1476
The use of induced pluripotent ...... ments for retinitis pigmentosa
@en
P2093
Hideyuki Okano
Kazuo Tsubota
Keiichiro Suzuki
Kenya Yuki
Kohnosuke Mitani
Shigeto Shimmura
Tetsu Yoshida
Wado Akamatsu
Yoko Ozawa
P2860
P2888
P356
10.1186/1756-6606-7-45
P577
2014-06-16T00:00:00Z
P5875
P6179
1010703526